Primary large-cell neuroendocrine carcinoma of the parotid gland: Immunohistochemical and molecular analysis of two cases

Modern Pathology

Volumn 13, Issue 5, 2000, Pages 554-561

  Nagao, Toshitaka ^a   Sugano, Isamu ^a   Ishida, Yasuo ^a   Tajima, Yasuo ^a   Munakata, Shigeru ^a   Asoh, Akira ^a   Yamazaki, Kazuto ^b   Muto, Hiroyuki ^b   Konno, Akiyoshi ^b   Kondo, Yoichiro ^b   Nagao, Koichi ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Bcl 2; Cyclin D1; K ras; Large cell neuroendocrine carcinoma; P16; P27(K)(i)(p)1; P53; Parotid gland; Salivary gland

Indexed keywords

PROTEIN BCL 2; PROTEIN P16; PROTEIN P27; PROTEIN P53;

ARTICLE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; MITOSIS RATE; NEUROENDOCRINE TUMOR; ONCOGENE K RAS; PAROTID GLAND CARCINOMA; POINT MUTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ROSETTE FORMATION; SALIVARY GLAND TUMOR; TUMOR SUPPRESSOR GENE;

EID: 0034032246     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880096     Document Type: Article

References (28)

1. Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB Jr, Nieman L, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma: an ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 1991;15:529-53.
2. Dresler CM, Ritter JH, Patterson GA, Ross E, Bailey MS, Wick MR Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of lung. Ann Thorac Surg 1997; 63:180-5.
3. Travis WD, Rush W, Flieder DB, Falk R, Fleming MV, Gal AA, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998;22:934-44.
4. Gilks CB, Young RH, Gersell DJ, Clement PB. Large cell neuroendocrine [corrected] carcinoma of the uterine cervix: a clinicopathologic study of 12 cases. Am J Surg Pathol 1997;21:905-14.
5. Chetty R, Batitang S, Govender D. Large cell neuroendocrine carcinoma of the thymus. Histopathology 1997;31:274-6.
6. Matsui K, Jin XM, Kitagawa M, Miwa A. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants. Arch Pathol Lab Med 1998;122:1010-7.
7. Hailemariam S, Gaspert A, Komminoth P, Tamboli P, Amin M. Primary, pure, large-cell neuroendocrine carcinoma of the urinary bladder. Mod Pathol 1998;11:1016-20.
8. Hui KK, Luna MA, Batsakis JG, Ordonez NG, Weber R. Undifferentiated carcinomas of the major salivary glands. Oral Surg Oral Med Oral Pathol 1990;69:76-83.
9. Larsson LG, Donner LR. Large cell neuroendocrine carcinoma of the parotid gland: fine needle aspiration, and light microscopic and ultrastructural study. Acta Cytol 1999;43: 534-6.
10. Nagao K, Matsuzaki O, Saiga H, Sugano I, Shigematsu H, Kaneko T, et al. Histopathologic studies of undifferentiated carcinoma of the parotid gland. Cancer 1982;50:1572-9.
11. Cawkwell L, Bell SM, Lewis FA, Dixon MF, Taylor GR, Quirke P. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 1993;67:1262-7.
12. Nagao T, Ishida Y, Sugano I, Tajima Y, Matsuzaki O, Hino T, et al. Epstein-Barr virus-associated undifferentiated carcinoma with lymphoid stroma of the salivary gland in Japanese patients: comparison with benign lymphoepithelial lesion. Cancer 1996;78:695-703.
13. Huntrakoon M. Neuroendocrine carcinoma of the parotid gland: a report of two cases with ultrastructural and immunohistochemical studies. Hum Pathol 1987;18:1212-7.
14. Scher RL, Feldman PS, Levine PA. Small-cell carcinoma of the parotid gland with neuroendocrine features. Arch Otolaryngol Head Neck Surg 1988;114:319-21.
15. Mair S, Phillips JI, Cohen R. Small cell undifferentiated carcinoma of the parotid gland: cytologic, histologic, immunohistochemical and ultrastructural features of a neuroendocrine variant. Acta Cytol 1989;33:164-8.
16. Gnepp DR, Wick MR. Small cell carcinoma of the major salivary glands: an immunohistochemical study. Cancer 1990;66:185-92.
17. Seifert G, Sobin L. Histological typing of salivary gland tumors (World Health Organization). 2nd ed. New York: Springer-Verlag; 1991.
18. Ellis GL, Auclair PL. Tumors of the Salivary Glands. Atlas of Tumor Pathology Washington, DC: Armed Forces Institute of Pathology; 1996.
19. Hall M, Peter G. Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancers. Adv Cancer Res 1996;68:67-108.
20. Elledge SJ, Winston J, Harper JW. A question of balance: the role of cyclin-kinase inhibitors in development and tumor-igenesis. Trends Cell Biol 1996;6:388-93.
21. Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, et al. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat Med 1997;3:227-30.
22. Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, et al. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res 1998; 58:542-8.
23. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368:753-56.
24. Przygodzki RM, Finkelstein SD, Langer JC, Swalsky PA, Fishback N, Bakker A, et al. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors: correlation with histological subtype and clinical outcome. Am J Pathol 1996; 148:1531-41.
25. Onuki N, Wistuba II, Travis WD, Virmani AK, Yashima K, Brambilla E, et al. Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer 1999;85:600-7.
26. Wistuba II, Thomas B, Behrens C, Onuki N, Lindberg G, Albores-Saavedra J, et al. Molecular abnormalities associated with endocrine tumors of the uterine cervix. Gynecol Oncol 1999;72:3-9.
27. Jiang SX, Kameya T, Shoji M, Shinada J, Yoshimura H. The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung. Mod Pathol 1999;12:362-9.
28. Chan JKC, Suster S, Wenig BM, Tsang WYW, Chan JBK, Lau ALW. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997;21:226-34.